An HLA-presented fragment of macrophage migration inhibitory factor is a therapeutic target for invasive breast cancer.

An HLA-presented fragment of macrophage migration inhibitory factor is a therapeutic target for invasive breast cancer. J Immunol. 2011 Jun 01; 186(11):6607-16.

View in: PubMed

subject areas

Amino Acid Sequence
Animals
Antibodies, Monoclonal
Antibody Affinity
Antibody Specificity
Apoptosis
Breast Neoplasms
Carcinoma, Ductal, Breast
Cell Line
Cell Line, Tumor
Cell Survival
Dose-Response Relationship, Drug
Female
HLA-A Antigens
HLA-A2 Antigen
Humans
Kinetics
Macrophage Migration-Inhibitory Factors
Mice
Mice, Nude
Peptides
Prognosis
Protein Binding
Xenograft Model Antitumor Assays

authors with profiles

William C Dooley
William H Hildebrand